RogerAGoldbergMD

Retinal Disease, Uveitis

Vitreoretinal Specialist, Bay Area Retina Associates

Dr. Goldberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Tufts Medical CenterFellowship, Surgical Retina and Vitreous, 2012 - 2014
University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 2009 - 2012
Mount Sinai Medical Center of FloridaInternship, Internal Medicine, 2008 - 2009
Yale School of MedicineClass of 2008

PubMed

108 citations
An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.
Roger A. Goldberg, Harry W. Flynn, Ryan F. Isom, Darlene Miller, Serafin Gonzalez
American Journal of Ophthalmology. 2012-02-01
124 citations
Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab.
Andre J. Witkin, Paul Hahn, Timothy G. Murray, J. Fernando Arevalo, Kevin J. Blinder
Journal of Vitreoretinal Diseases. 2020-07-01
9 citations
Fuchs endothelial corneal dystrophy: clinical characteristics of surgical and nonsurgical patients
Roger A. Goldberg, Sabri Raza, Eric Walford, William J. Feuer, Jeffrey L. Goldberg
Clinical Ophthalmology. 2014-09-09

Bay Area Retina Associates (BARA) Offers the First-Ever FDA-Approved Treatment for Geographic Atrophy (GA), the Advanced Dry Form of Age-Related Macular Degeneration (AMD)March 1st, 2023
Emmecell Exits Stealth Mode as FDA Greenlights Clinical Trials of Cornea Cell TherapySeptember 22nd, 2020
Leading Ophthalmologists to Discuss the Value of IRIDEX Solutions at AAOOctober 23rd, 2018
Join now to see all